Ekso Bionics Holdings Inc
NASDAQ:EKSO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK |
|
Bank of New York Mellon Corp
NYSE:BK
|
US |
Ekso Bionics Holdings Inc
Research & Development
Ekso Bionics Holdings Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Research & Development
-$3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Research & Development
-$251.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Ekso Bionics Holdings Inc
Glance View
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.
See Also
What is Ekso Bionics Holdings Inc's Research & Development?
Research & Development
-3m
USD
Based on the financial report for Dec 31, 2025, Ekso Bionics Holdings Inc's Research & Development amounts to -3m USD.
What is Ekso Bionics Holdings Inc's Research & Development growth rate?
Research & Development CAGR 10Y
7%
Over the last year, the Research & Development growth was 22%. The average annual Research & Development growth rates for Ekso Bionics Holdings Inc have been 6% over the past three years , -4% over the past five years , and 7% over the past ten years .
